Table 3.
Variable | Category | N | 2-yr Surv (%) | 95% CI | P |
---|---|---|---|---|---|
Sex | F | 24 | 51 | 30–85 | 0.04 |
M | 32 | 76 | 61–95 | ||
Age | <=60 | 31 | 75 | 58–98 | 0.52 |
>60 | 25 | 58 | 40–85 | ||
Extrahepatic Disease | No | 39 | 74 | 59–93 | 0.07 |
Yes | 17 | 49 | 28–87 | ||
CRS | 0–2 | 43 | 74 | 59–92 | 0.03 |
3–4 | 13 | 42 | 19–93 | ||
Electrode | 1 | 12 | 51 | 27–93 | 0.28 |
2 | 28 | 61 | 44–85 | ||
3 | 16 | 100 | - | ||
Prior HAIC | No | 32 | 56 | 39–80 | 0.15 |
Yes | 24 | 84 | 68–100 | ||
* Nodal Status of Primary | Negative | 14 | 71 | 48–100 | 0.44 |
Positive | 42 | 29 | 14–61 | ||
* Number of Tumors | Solitary | 41 | 46 | 30–70 | 0.05 |
Multiple | 15 | 37 | 17–78 | ||
* DFI | >12m | 16 | 62 | 40–95 | 0.94 |
<12m | 40 | 31 | 16–61 | ||
* Size | ≤3cm | 51 | 47 | 32–69 | 0.1 |
>3cm | 5 | 20 | 3–100 |
factor included in CRS; CRS= clinical risk score